Delivery Order SPE2DB20D2104-SPE2DB22FR84Z

Award Date 2/16/22
Potential Completion Date 2/17/22
Potential Value $24K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the supply of Nurtec ODT 75 mg tablets. The contract has a ceiling value of $2,895.86 and a completion date of November 8, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Nurtec ODT 75 mg tablets, with a total ceiling value of $10,846.07 and an ultimate completion date of November 27, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $17,673.45 and provides the DLA with Nurtec ODT 75 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through March 1, 2024. It was awarded on February 29, 2024, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $24,745.08 for the supply of Nurtec ODT 75 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Nurtec ODT 75 mg tablets. The contract has a firm fixed price and a ceiling value of $47,726.98. It is a delivery order with an ultimate completion date of September 19, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablets. The contract has a Firm Fixed Price of $4,153.07 and a completion date of June 16, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. The IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide NURTEC ODT 75 MG TABLET 8S. The contract has a ceiling value of $9,582.72 and runs through August 31, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a prescription medication, and has a ceiling value of $27,061.23. The contract is a firm fixed-price, delivery order type with an ultimate completion date of June 7, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablets. The contract has a ceiling value of $11,135.78 and is a firm fixed-price delivery order with an ultimate completion date of April 11, 2025. The contract is not set aside and is for the provision of prescription medication to support federal medical procurement needs, particularly for military and veteran...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nurtec ODT 75 mg tablets. The contract has a ceiling value of $28,492.11 and a period of performance through May 5, 2025. It is a firm-fixed-price contract, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FR84Z
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Nurtec ODT 75 mg tablets, a prescription medication. The total ceiling value of the award is $24,374.48, with a completion date of February 17, 2022. The contract is a firm-fixed-price delivery order, with no set-aside designation. This award is a part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 11:57 AM